Viral Load and Risk of Tuberculosis in HIV Infection

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e51-3. doi: 10.1097/QAI.0000000000000834.

Authors

Christoph Lange¹, Frank van Leth, Martina Sester; TBnet

Affiliation

¹ *Clinical Infectious Diseases, Research Center Borstel, Clinical tuberculosis unit, German Center for Infection Research (DZIF), Borstel, Germany†Department of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, The Netherlands‡Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.

PMID: 26761521
DOI: 10.1097/QAI.0000000000000834

No abstract available

Publication types

Letter

MeSH terms

Anti-Retroviral Agents / therapeutic use
Follow-Up Studies
HIV Infections / complications*
HIV Infections / drug therapy
HIV Infections / virology
Humans
Incidence
Mycobacterium tuberculosis / isolation & purification*
RNA, Viral / blood
Risk
Tuberculosis / complications*
Viral Load*

Substances

Anti-Retroviral Agents
RNA, Viral